News about Global Pharma

Cosette Pharmaceuticals Welcomes Vincent Colicchio as Senior Vice President of Operations

Cosette Pharmaceuticals Welcomes Vincent Colicchio as Senior Vice President of Operations

In this role, Vin will lead Cosette’s manufacturing, global supply chain, and operational strategy, ensuring efficiency, and supply continuity as the company continues its strong trajectory of growth and transformation.

Global Pharma | 11/02/2025 | By Aishwarya 540

US FDA Approves Abbvie's EMBLAVEO

US FDA Approves Abbvie's EMBLAVEO

AbbVie announced that the US Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam), as the first and only fixed-dose, intravenous, monobactam/β-lactamase inhibitor combination antibiotic.

Global Pharma | 10/02/2025 | By Manvi 640

BioRay's ROR1-Targeting Dual-Epitope ADC BR111 Gains NMPA Clinical Trial Approval

BioRay's ROR1-Targeting Dual-Epitope ADC BR111 Gains NMPA Clinical Trial Approval

BioRay Pharmaceutical announced that China's NMPA has accepted the clinical trial application for BR111, a first-in-class bi-paratopic ADC targeting ROR1 for the treatment of hematological malignancies and solid tumours.

Global Pharma | 10/02/2025 | By Manvi 394

Sai Life Sciences Eyes Global Expansion as Revenue Hits INR 1,115.1 Crore

Sai Life Sciences Eyes Global Expansion as Revenue Hits INR 1,115.1 Crore

The company reported a 15 percent increase in revenue and a 36 percent rise in net profit compared to the same period last year, driven by strong execution, expanding capacity, and deepening customer relationships.

Global Pharma | 10/02/2025 | By Aishwarya 1148

Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation

Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation

As an independent company, Tanabe Pharma will continue to build on its legacy of medical innovation while developing new opportunities for growth through business development, licensing activities, enhanced R&D productivity, commercialization and strategic acquisitions.

Global Pharma | 10/02/2025 | By Aishwarya 448

ClariMed Opens its Advanced Simulated Use Research Center in Cambridge, UK

ClariMed Opens its Advanced Simulated Use Research Center in Cambridge, UK

The new purpose-built facility features innovative design elements that enhance the quality and scope of human factors studies, including a dedicated observation area on the second floor that provides unparalleled visibility of participant interactions.

Global Pharma | 07/02/2025 | By Manvi 224

Delta Development Team Launches its Cutting-Edge Tricon Refrigerated Containers

Delta Development Team Launches its Cutting-Edge Tricon Refrigerated Containers

Delta Development Team, Inc (DDT) is pushing the boundaries of innovative storage and transport solutions for temperature-sensitive goods with the development of advanced, large-scale refrigerated Tricon containers.

Global Pharma | 07/02/2025 | By Manvi 332

Aurobindo Pharma to Use Solar Power in Company's Operations to Promote Sustainability

Aurobindo Pharma to Use Solar Power in Company's Operations to Promote Sustainability

Hyderabad-based Aurobindo Pharma has signed a power purchase agreement with Swarnaaskshu Solar Power to procure solar energy under a captive arrangement. It will be investing up to INR 10.40 crore for a 26 percent stake in the company's planned 30 MW AC (40 MW DC) solar plant in Telangana.

Global Pharma | 07/02/2025 | By Manvi 800

Bio-Thera's BAT2506 Biosimilar to Simponi Gains EMA Review for EU Approval

Bio-Thera's BAT2506 Biosimilar to Simponi Gains EMA Review for EU Approval

The reference medicine golimumab has been approved in Europe for several indications including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis.

Global Pharma | 07/02/2025 | By Abha 534

Eli Lilly's Omvoh Shows Long-Term Efficacy in Crohn's Disease: VIVID-2 Study Results Announced

Eli Lilly's Omvoh Shows Long-Term Efficacy in Crohn's Disease: VIVID-2 Study Results Announced

Omvoh works to reduce inflammation within the gastrointestinal tract by targeting a specific protein, interleukin-23p19 (IL-23p19), which is a key contributor to intestinal inflammation.

Global Pharma | 07/02/2025 | By Abha 523

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members